render_searchpagetitle(); ?> render_searchpagemetatags(); ?>
Search - Add URL - Join The Lab
Found 4750 results for any of the keywords moderately to severely active. Time 0.014 seconds.
Ulcerative Colitis Treatment - SKYRIZI® (risankizumab-rzaa)SKYRIZI® is indicated for the treatment of moderately to severely active ulcerative colitis in adults. See Important Safety and Prescribing Information.
RINVOQ® (upadacitinib) for Rheumatoid ArthritisLearn about RINVOQ® (upadacitinib) for the treatment of moderate to severe Rheumatoid Arthritis (RA) in adult TNFi-IR patients. See full Prescribing Information and Important Safety Information, including BOXED WARNING.
Crohn s Disease Treatment - SKYRIZI® (risankizumab-rzaa)SKYRIZI® is indicated for the treatment of moderate to severe Crohn’s disease in adults. See Important Safety and Prescribing Information.
HUMIRA® (adalimumab) for Pediatric Crohn s DiseaseLearn about HUMIRA efficacy and safety data in maintaining clinical remission and response in children with moderate to severe Crohn s disease (CD). See Important Safety Information, including BOXED WARNING.
HUMIRA® (adalimumab) for Juvenile Idiopathic ArthritisDiscover HUMIRA efficacy and safety data on disease flare, signs and symptoms of moderate to severe polyarticular Juvenile Idiopathic Arthritis (JIA). See Important Safety Information, including BOXED WARNING.
SKYRIZI® (risankizumab-rzaa) HCP - Official Site by AbbVie Inc.A biologic treatment for adult patients living with moderate to severe Plaque Psoriasis, adults with active Psoriatic Arthritis, adults with moderate to severe active Crohn s Disease, and adults with moderate to severe U
HUMIRA® (adalimumab) for hidradenitis suppurativa (HS)Learn about the efficacy and safety data of HUMIRA in treating moderate to severe hidradenitis suppurativa (HS). See Important Safety Information, including BOXED WARNING.
HUMIRA® (adalimumab) | For Healthcare ProfessionalsHUMIRA is indicated for the treatment of rheumatology, dermatology, and gastroenterology indications. Review efficacy, safety data, and more.
RINVOQ® (upadacitinib) for Crohn s DiseaseLearn about RINVOQ® for the treatment of moderate to severe Crohn s Disease (CD) in adult TNFi-IR patients. See full Prescribing Information and Important Safety Information, including BOXED WARNING.
RINVOQ® (upadacitinib) for Ulcerative ColitisLearn about RINVOQ® (upadacitinib) for the treatment of moderate to severe Ulcerative Colitis (UC) in adult TNFi-IR patients. See full Prescribing Information and Important Safety Information, including BOXED WARNING.
|
Sponsored Results
Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less
Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less | ||
|
To process your query we did a search for the keyphrases moderately, moderately to severely active, to severely, to severely active, severely << Previous - 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 - 11 - 12 - 13 - 14 - 15 - Next >> |
|
Didn't find what you were searching for? You can add a new website to the index, remove your site from the search results using the robots.txt protocol or tell us how you would like the results by sending us a message using the email address below:
|
Recent searches:
GO - ZK - guest names in - BY - GY
PI - matches for today - CF - linux distro - how to use instagram
Copyright (C) 2007 - 2025 Text Ad King and SecretSearchEngineLabs.com. All Rights Reserved.
Terms and Conditions - Privacy Policy - Advertising - About Us - Login